Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
February 20, 2022
[Efficacy and survival outcomes of dose-dense carboplatin plus paclitaxel as neoadjuvant chemotherapy for triple-negative breast cancer]
Y Liu, M Xiu, X Wang, et al.
Scientific Reports
|
September 22, 2016
A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment
F Du, P Yuan, Z T Zhao, et al.
Scientific Reports
|
October 15, 2016
Erratum: A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment
F Du, P Yuan, Z T Zhao, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
February 18, 2021
[Progress on clinical trials of cancer drugs in China, 2020]
D W Wu, H Y Huang, Y Tang, et al.
Zhonghua Yi Xue Za Zhi
|
August 15, 2020
[Phase Ⅲ randomized controlled, multicenter, prospective study of recombinant anti-HER2 humanized monoclonal antibody (Cipterbin) combined with vinorelbine in patients with HER2 positive metastatic breast cancer: the HOPES Study]
L Bian, B H Xu, L J Di, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
November 18, 2021
[Correlation between nUGT1A1 gene polymorphisms and adverse events of irinotecan plus S-1 for patients with recurrent or metastatic esophageal squamous cell carcinoma: a prospective, open-label, randomized controlled trial (ESWN 01)]
X Wang, Y Liu, J X Huang, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology
|
April 29, 2022
[Consensus of experts on the oral health management and medical risk prevention for the patients with chronic airway diseases (2022 edition)]
Z M Wang, Q Liu, Y X Liu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
March 22, 2022
[Progress on clinical trials of common gastrointestinal cancer drugs in China from 2012 to 2021]
H Y Huang, D W Wu, Q Zhu, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology
|
April 29, 2022
[Consensus of experts on the medical risk prevention for the patients with cardiovascular diseases during dental treatment (2022 edition)]
J Zhang, G H Su, X D Zhang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
March 6, 2020
[Progress on clinical trials of cancer drugs in China, 2019]
H Y Huang, D W Wu, H X Wang, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
February 20, 2022
[Efficacy and survival outcomes of dose-dense carboplatin plus paclitaxel as neoadjuvant chemotherapy for triple-negative breast cancer]
Y Liu, M Xiu, X Wang, et al.
Scientific Reports
|
September 22, 2016
A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment
F Du, P Yuan, Z T Zhao, et al.
Scientific Reports
|
October 15, 2016
Erratum: A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment
F Du, P Yuan, Z T Zhao, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
February 18, 2021
[Progress on clinical trials of cancer drugs in China, 2020]
D W Wu, H Y Huang, Y Tang, et al.
Zhonghua Yi Xue Za Zhi
|
August 15, 2020
[Phase Ⅲ randomized controlled, multicenter, prospective study of recombinant anti-HER2 humanized monoclonal antibody (Cipterbin) combined with vinorelbine in patients with HER2 positive metastatic breast cancer: the HOPES Study]
L Bian, B H Xu, L J Di, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
November 18, 2021
[Correlation between nUGT1A1 gene polymorphisms and adverse events of irinotecan plus S-1 for patients with recurrent or metastatic esophageal squamous cell carcinoma: a prospective, open-label, randomized controlled trial (ESWN 01)]
X Wang, Y Liu, J X Huang, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology
|
April 29, 2022
[Consensus of experts on the oral health management and medical risk prevention for the patients with chronic airway diseases (2022 edition)]
Z M Wang, Q Liu, Y X Liu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
March 22, 2022
[Progress on clinical trials of common gastrointestinal cancer drugs in China from 2012 to 2021]
H Y Huang, D W Wu, Q Zhu, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology
|
April 29, 2022
[Consensus of experts on the medical risk prevention for the patients with cardiovascular diseases during dental treatment (2022 edition)]
J Zhang, G H Su, X D Zhang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
March 6, 2020
[Progress on clinical trials of cancer drugs in China, 2019]
H Y Huang, D W Wu, H X Wang, et al.
Page
of 7